Miao Run-Qing, Zhu Feng-Ya, Wang Tian-Yu, Yin Shao, Shuai Chen, Li Tao, Li Zhi, Luo Lan, Yang Bin
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province 610075, China.
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province 610075, China.
Complement Ther Med. 2025 Aug;91:103178. doi: 10.1016/j.ctim.2025.103178. Epub 2025 Apr 19.
BACKGROUND: In recent years, research on acupuncture for post-stroke depression (PSD) has grown significantly, yet findings remain inconsistent. Few researchers have conducted comprehensive assessments of systematic reviews (SRs) in this area. Consequently, there is a need for a thorough and objective synthesis of clinical evidence regarding acupuncture's effectiveness in treating PSD. OBJECTIVE: To evaluate and synthesize evidence on the efficacy and safety of acupuncture for PSD through systematic reviews, offering valuable insights for clinical practice and guiding future research directions. METHODS: We searched PubMed, Embase, Web of Science, Cochrane Library, CNKI, SinoMed, Wanfang, VIP and Google Scholar databases for relevant literature. The search covered publications from database inception to September 10, 2024. Literature selection and data extraction were independently performed by two reviewers. The methodological quality, bias risk, and evidence level of included SRs were assessed using AMSTAR 2, ROBIS, and GRADE tools. The corrected covered area (CCA) was calculated to assess overlap in original studies. Data from included SRs were subjected to quantitative or descriptive analysis. RESULTS: A total of 38 SRs on acupuncture for PSD were included. After assessment using AMSTAR 2, one SR was rated as moderate quality, two as low quality, and 35 as very low quality. According to ROBIS, 21 SRs were classified as high risk of overall bias, and 17 as low risk. Acupuncture showed potential to improve depressive symptoms, stroke-related symptoms, and activities of daily living in PSD patients, though the quality of evidence is limited. Some studies suggested possible effects on cognitive function, biomarkers, sleep quality, and Traditional Chinese Medicine syndromes, but these findings require further validation with higher-quality research. While no serious adverse effects were reported in the reviewed studies, more rigorous safety evaluations are needed before definitive conclusions about acupuncture's safety for PSD can be made. CONCLUSION: Acupuncture shows potential as a treatment for PSD, though more high-quality research is needed to establish its effectiveness and safety. Currently, the majority of systematic reviews exhibit deficiencies in protocol pre-registration, documentation of excluded studies, and disclosure of funding sources, resulting in systematic reviews of suboptimal quality. Current evidence suggests possible benefits for depressive symptoms, stroke-related symptoms, activities of daily living, cognitive function, biomarkers, sleep quality, and TCM syndromes, but these findings should be interpreted cautiously given the limitations in study quality. Further high-quality studies are needed to confirm the efficacy and safety of acupuncture for PSD.
背景:近年来,关于针刺治疗中风后抑郁症(PSD)的研究显著增加,但研究结果仍不一致。很少有研究者对该领域的系统评价(SRs)进行全面评估。因此,需要对针刺治疗PSD有效性的临床证据进行全面、客观的综合分析。 目的:通过系统评价评估并综合针刺治疗PSD的疗效和安全性证据,为临床实践提供有价值的见解并指导未来研究方向。 方法:我们检索了PubMed、Embase、Web of Science、Cochrane图书馆、中国知网、中国生物医学文献数据库、万方数据库、维普数据库和谷歌学术数据库中的相关文献。检索涵盖从数据库建立至2024年9月10日的出版物。文献筛选和数据提取由两名评价员独立进行。使用AMSTAR 2、ROBIS和GRADE工具评估纳入SRs的方法学质量、偏倚风险和证据水平。计算校正覆盖面积(CCA)以评估原始研究中的重叠情况。对纳入SRs的数据进行定量或描述性分析。 结果:共纳入38篇关于针刺治疗PSD的SRs。使用AMSTAR 2评估后,1篇SR被评为中等质量,2篇为低质量,35篇为极低质量。根据ROBIS,21篇SRs被归类为总体偏倚高风险,17篇为低风险。针刺显示出改善PSD患者抑郁症状、中风相关症状和日常生活活动能力的潜力,尽管证据质量有限。一些研究表明对认知功能、生物标志物、睡眠质量和中医证候可能有影响,但这些发现需要更高质量的研究进一步验证。虽然在纳入的研究中未报告严重不良反应,但在对针刺治疗PSD的安全性得出明确结论之前,需要更严格的安全性评估。 结论:针刺显示出治疗PSD的潜力,但需要更多高质量研究来确定其有效性和安全性。目前,大多数系统评价在方案预注册、排除研究的记录和资金来源披露方面存在不足,导致系统评价质量欠佳。当前证据表明对抑郁症状、中风相关症状、日常生活活动能力、认知功能、生物标志物、睡眠质量和中医证候可能有益,但鉴于研究质量的局限性,这些发现应谨慎解读。需要进一步的高质量研究来证实针刺治疗PSD的疗效和安全性。
Complement Ther Med. 2025-8
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2022-9-23
Cochrane Database Syst Rev. 2014-4-29
Cochrane Database Syst Rev. 2017-4-24
Cochrane Database Syst Rev. 2017-1-14